Global Veterinary Follicle Stimulating Hormones (FSH) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Veterinary Follicle Stimulating Hormones (FSH) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Follicle-stimulating hormone is a hormone secreted by basophils in the anterior pituitary gland. Its component is glycoprotein, and its main function is to promote the maturation of follicles. Follicle stimulating hormone can promote the proliferation and differentiation of granulosa cells in the follicle, and promote the growth of the entire ovary. Follicle Stimulating Hormone (FSH) is an important part of the reproductive system. It is responsible for the growth of follicles. This report studies veterinary follicle stimulating hormone, not human FSH.

Market Overview:

The latest research study on the global Veterinary Follicle Stimulating Hormones (FSH) market finds that the global Veterinary Follicle Stimulating Hormones (FSH) market reached a value of USD 42.62 million in 2022. It’s expected that the market will achieve USD 57.87 million by 2028, exhibiting a CAGR of 5.23% during the forecast period.

People's demand for protein is rising

With the continuous improvement of people's living standards, dietary concepts are also constantly updated, and daily eating habits have shifted to high-protein, low-fat animal food. Take the United States as an example. In the past ten years, the per capita consumption of lamb in the United States has been stable at about 1 pound per person per year, and nearly 20% of the consumption of lamb occurred during the spring break. Urban shoppers are most likely to consume lamb, with the highest consumption on the east and west coasts. The American Lamb Board (ALB) has approved a new long-term plan for 2018-2022. The strategic goal of the plan is to increase the demand for American lamb by 2% each year over the next five years, and the total demand will increase by 10%. Lamb is characterized by more lean meat, less fat content, fresh meat quality, rich nutrition, easy digestion, and relatively low cholesterol content, so it is favored by consumers. The increasing demand for protein will promote the development of the aquaculture industry, thereby promoting the development of follicle stimulating hormone for animals.

Veterinary follicle stimulating hormone extraction technology requires high

At present, the hormones available on the market are almost entirely obtained from the pituitary gland extracts of pigs slaughtered in slaughterhouses, and there is less FSH in the pituitary gland. Although veterinary follicle stimulating hormone is widely used in cattle and sheep and other breeding industries, there are some factors that affect the quality of extracting follicle stimulating hormone from the pituitary gland. For example, the product has a high risk of contamination by pathogens and is easily affected by other hormones. Other hormones will interfere with the assisted fertilization process to varying degrees, and will also cause significant differences in the active ingredients between each production batch. To a certain extent, this requires manufacturers to continuously improve their own technical requirements to ensure product quality.

The market is relatively concentrated

At present, there are relatively few manufacturers in the market that can invest in Veterinary Follicle Stimulating Hormones (FSH) synthesis. This also means that most of the profits in the market are concentrated in the hands of a few players. On the one hand, this raises the barriers to entry for the industry to a certain extent, including technology and capital barriers. On the other hand, the existence of collusion and coordination behaviors among a few companies and the behavior of restricting competition through market entry barriers have weakened the competitiveness of the market.

Region Overview:

In global comparison, a significant portion of the revenue was generated in Europe (25.76% in 2022).

Company Overview:

Vetoquinol is one of the major players operating in the Veterinary Follicle Stimulating Hormones (FSH) market, holding a share of 61.2% in 2023.

Vetoquinol

Vetoquinol ranks among the top 10 veterinary drug laboratories in the world, first as an independent family business. Firmly committed to its values, it has always maintained a close relationship with its veterinary customers.

ICPbio

ICPbio Reproduction produces a full range of embryo-friendly media for the embryo transfer market. ICPbio Reproduction conducts all production activities in a GMP (Good Manufacturing Practice) facility.

Segmentation Overview:

As for product types, the Pig segment held the largest market share in 2022.

Application Overview:

The market's largest segment by application is the segment Bovine, with a market share of 60.36% in 2022.

Key Companies in the global Veterinary Follicle Stimulating Hormones (FSH) market covered in Chapter 3:

Ningbo Second Hormone
Vetoquinol
ICPbio
Calier
Reprobiol

In Chapter 4 and Chapter 14.2, on the basis of types, the Veterinary Follicle Stimulating Hormones (FSH) market from 2018 to 2029 is primarily split into:

Pig
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Veterinary Follicle Stimulating Hormones (FSH) market from 2018 to 2029 covers:

Bovine
Sheep
Horse
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)